These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 18502304)

  • 1. Type 1 diabetes, hyperglycaemia, and the heart.
    Retnakaran R; Zinman B
    Lancet; 2008 May; 371(9626):1790-9. PubMed ID: 18502304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epidemiology of cardio-vascular complications of diabetes].
    Grimaldi A; Heurtier A
    Diabetes Metab; 1999 Jun; 25 Suppl 3():12-20. PubMed ID: 10421988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-challenge hyperglycaemia is associated with premature death and macrovascular complications.
    Qiao Q; Tuomilehto J; Borch-Johnsen K
    Diabetologia; 2003 Mar; 46 Suppl 1():M17-21. PubMed ID: 12652354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes.
    Dailey G
    Clin Ther; 2011 Jun; 33(6):665-78. PubMed ID: 21704233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular risk factors in type 2 diabetes: the role of hyperglycaemia.
    Massi-Benedetti M; Federici MO
    Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 4():S120-3. PubMed ID: 10522835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular risk in the young type 1 diabetes population with a low 10-year, but high lifetime risk of cardiovascular disease.
    McVeigh GE; Gibson W; Hamilton PK
    Diabetes Obes Metab; 2013 Mar; 15(3):198-203. PubMed ID: 22998614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperglycaemia and the vessel wall: the pathophysiological aspects on the atherosclerotic burden in patients with diabetes.
    Ceriello A
    Eur J Cardiovasc Prev Rehabil; 2010 May; 17 Suppl 1():S15-9. PubMed ID: 20489415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postprandial dysmetabolism and cardiovascular disease in type 2 diabetes.
    Tushuizen ME; Diamant M; Heine RJ
    Postgrad Med J; 2005 Jan; 81(951):1-6. PubMed ID: 15640422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-challenge hyperglycaemia rather than fasting hyperglycaemia is an independent risk factor of cardiovascular disease events.
    Gao W; Qiao Q; Tuomilehto J
    Clin Lab; 2004; 50(9-10):609-15. PubMed ID: 15481637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperglycaemia as a determinant of cognitive decline in patients with type 1 diabetes.
    Wessels AM; Scheltens P; Barkhof F; Heine RJ
    Eur J Pharmacol; 2008 May; 585(1):88-96. PubMed ID: 18396273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycaemic control is essential for effective cardiovascular risk reduction across the type 2 diabetes continuum.
    Karasik A
    Ann Med; 2005; 37(4):250-8. PubMed ID: 16019723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of cardiovascular complications in type 2 diabetes mellitus.
    Meigs JB
    Acta Diabetol; 2003 Dec; 40 Suppl 2():S358-61. PubMed ID: 14704869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse models for studies of cardiovascular complications of type 1 diabetes.
    Shen X; Bornfeldt KE
    Ann N Y Acad Sci; 2007 Apr; 1103():202-17. PubMed ID: 17376839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic dyslipidemia or 'diabetes lipidus'?
    Muačević-Katanec D; Reiner Z
    Expert Rev Cardiovasc Ther; 2011 Mar; 9(3):341-8. PubMed ID: 21438813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postprandial hyperglycaemia and vascular damage--the benefits of acarbose.
    Båvenholm PN; Efendic S
    Diab Vasc Dis Res; 2006 Sep; 3(2):72-9. PubMed ID: 17058626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Postprandial hyperglycemia. Postprandial blood glucose fluctuations, cardiovascular disease and late diabetic complications].
    Madsbad S; Brock B; Schmitz O
    Ugeskr Laeger; 2003 Aug; 165(33):3149-53. PubMed ID: 12968409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of blood glucose concentrations on the development of chronic complications of diabetes mellitus.
    Swidan SZ; Montgomery PA
    Pharmacotherapy; 1998; 18(5):961-72. PubMed ID: 9758308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics.
    Kavey RE; Allada V; Daniels SR; Hayman LL; McCrindle BW; Newburger JW; Parekh RS; Steinberger J; ; ; ; ; ; ; ;
    Circulation; 2006 Dec; 114(24):2710-38. PubMed ID: 17130340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural history of cardiovascular disease in patients with diabetes: role of hyperglycemia.
    Milicevic Z; Raz I; Beattie SD; Campaigne BN; Sarwat S; Gromniak E; Kowalska I; Galic E; Tan M; Hanefeld M
    Diabetes Care; 2008 Feb; 31 Suppl 2():S155-60. PubMed ID: 18227478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intensive glucose control in type 2 diabetes: is it harmful, needless or maybe useful in reducing cardiovascular risk?].
    Consoli A
    G Ital Cardiol (Rome); 2010 Dec; 11(12 Suppl 2):7S-11S. PubMed ID: 21361050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.